EP18.23: Analysis of determinants of fetal fraction in cell‐free fetal DNA testing

Fetal fraction (FF) ensures that there is enough placental cell-free DNA (cfDNA) in maternal plasma to produce a reliable result. The detection rates decrease with reducing FF, leading to a “no call” result. Therefore, it is crucial to identify the factors contributing to low FF. Our study aims to investigate and analyse the factors that contribute to low FF in cffDNA testing and to provide a comprehensive understanding of the determinants of low FF to improve the performance of cffDNA testing as a prenatal screening tool. A retrospective cohort study encompassing all antenatal women who underwent cffDNA testing for fetal aneuploidies at the Maternal and Fetal Medicine Unit during the study period(2019-2023) Next Generation Sequencing was employed to analyse fetal and maternal alleles and thus ascertain the proportion of cell-free DNA (cfDNA) originating from the fetus. Multivariable regression analysis was utilised to identify the significant determinants of fetal cell fraction. Fetal fraction exhibited a significant positive linear correlation with gestational age (r= 0.169), and a significant negative correlation with maternal age (r= -0.103) and BMI (r=-0.281).Low fetal fraction was significantly associated with advanced maternal age (≥35 years), high BMI (≥35), IVF pregnancies, maternal overt diabetes/autoimmune diseases, IVF pregnancies and low serum biochemical markers (PAPPA and HCG). There were no significant differences found in twin pregnancies or between male and female fetuses. Low fetal fraction correlated significantly with higher rates of fetal aneuploidies, increased risk of pre-eclampsia, severe pre-eclampsia with impending symptoms, small for gestational age babies, fetal growth restriction and NICU stay. A comprehensive understanding of the factors influencing low fetal fraction enhances the interpretation of this parameter, aiding in the management of women with inconclusive cffDNA testing results. Additionally, these women can be counselled about potential adverse maternal and perinatal outcomes associated with low fetal fraction.

Authors

Publication Details

Journal
Ultrasound in Obstetrics and Gynecology
Published
2024-09-01
DOI
https://doi.org/10.1002/uog.28759
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EP18.23: Analysis of determinants of fetal fraction in cell‐free fetal DNA testing

Devanand K. Shenoy, Brinda Sabu, M.S. Latha, V. R
Ultrasound in Obstetrics and Gynecology
Prenatal Screening and Diagnostics
article

EP18.23: Analysis of determinants of fetal fraction in cell‐free fetal DNA testing

Devanand K. Shenoy, Brinda Sabu, M.S. Latha, V. R
article en

Abstract

Fetal fraction (FF) ensures that there is enough placental cell-free DNA (cfDNA) in maternal plasma to produce a reliable result. The detection rates decrease with reducing FF, leading to a “no call” result. Therefore, it is crucial to identify the factors contributing to low FF. Our study aims to investigate and analyse the factors that contribute to low FF in cffDNA testing and to provide a comprehensive understanding of the determinants of low FF to improve the performance of cffDNA testing as a prenatal screening tool. A retrospective cohort study encompassing all antenatal women who underwent cffDNA testing for fetal aneuploidies at the Maternal and Fetal Medicine Unit during the study period(2019-2023) Next Generation Sequencing was employed to analyse fetal and maternal alleles and thus ascertain the proportion of cell-free DNA (cfDNA) originating from the fetus. Multivariable regression analysis was utilised to identify the significant determinants of fetal cell fraction. Fetal fraction exhibited a significant positive linear correlation with gestational age (r= 0.169), and a significant negative correlation with maternal age (r= -0.103) and BMI (r=-0.281).Low fetal fraction was significantly associated with advanced maternal age (≥35 years), high BMI (≥35), IVF pregnancies, maternal overt diabetes/autoimmune diseases, IVF pregnancies and low serum biochemical markers (PAPPA and HCG). There were no significant differences found in twin pregnancies or between male and female fetuses. Low fetal fraction correlated significantly with higher rates of fetal aneuploidies, increased risk of pre-eclampsia, severe pre-eclampsia with impending symptoms, small for gestational age babies, fetal growth restriction and NICU stay. A comprehensive understanding of the factors influencing low fetal fraction enhances the interpretation of this parameter, aiding in the management of women with inconclusive cffDNA testing results. Additionally, these women can be counselled about potential adverse maternal and perinatal outcomes associated with low fetal fraction.

Ultrasound in Obstetrics and GynecologyVol. 64(S1)
Zero hunger
Openalex Percentile: Top 76%
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EP18.23: Analysis of determinants of fetal fraction in cell‐free fetal DNA testing — Devanand K. Shenoy, Brinda Sabu, et al. · Ultrasound in Obstetrics and Gynecology (2024) | TGRS Research Map | TGRS